IL1B and breast carcinoma: Multiple inflammatory factors secreted by aggressive metastatic MDA‐MB‐231 breast cancer cells, including extremely high concentrations of IL1β, were able to induce NF‐κB signaling and secretion of inflammatory cytokines and chemokines in bystander cells (Escobar et al., 2015).